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Videodensitometric blood flow analysis of
abdominal aortic aneurysm and intravascular
coagulation
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Objective: We investigated the relation between flow pattern in abdominal aortic aneurysm (AAA) and intravascular
coagulopathy characterized by increased fibrin degradation product D-dimer (FDP-DD) or thrombin-antithrombin
complex (TAT).
Materials andMethods:The ratio of AAAmaximum endoluminal diameter (diameter of flow channel) (n 23) to diameter
of the aorta between the superior mesenteric and renal arteries (R ratio) was measured with three-dimensional computed
tomography angiography. Digital subtraction angiography was performed with 20 mL (10 mL/s) of contrast agent
injected from the suprarenal portion of the abdominal aorta. The duration between the time when average gray scale in
the AAA reached maximum and average region of interest gray scale decreased to half-maximum (bolus transit time in
AAA [BTTAAA]) was calculated.
Results: Single correlation coefficient with statistic significance was detected between R ratio and BTTAAA (BTTAAA 
2.54 R ratio 3.65; r2 .30; P .042). Among the three-dimensional morphologic and videodensitometric variants,
BTTAAA was the most determinant factor associated with FDP-DD (FDP-DD 8.647 2.029 BTTAAA; r2 .448;
P  .005). The most efficient predictors for TAT were maximum AAA endoluminal diameter (Rendomax) and BTTAAA
(TAT   14.007  2.102  BTTAAA  0.296  Rendomax, r2  .360; P  .0069).
Conclusions Our findings suggest a close link between abnormal flow pattern in AAA and activation of the coagulation-
fibrinolysis system. Videodensitometric blood flow analysis can be useful in investigation of the pathophysiology of
phenomena related to abnormal flow field in AAA. (J Vasc Surg 2003;38:340-5.)
Abnormalities in coagulation and fibrinolytic activity
may occur in conjunction with abdominal aortic aneurysm
(AAA).1 AAA may activate the coagulation and fibrinolysis
system, which is characterized by increased fibrin degrada-
tion product D-dimer (FDP-DD) or thrombin-antithrom-
bin III complex (TAT). The severity of activation of the
coagulation-fibrinolytic system is influenced by the anat-
omy of the aneurysmwalls.2 On the other hand, in biorheo-
logic studies aneurysm deformation caused disturbed flow
pattern in the aneurysm.3 Under these circumstances, an
abnormal flow field and resultant shear stress may activate
intravascular coagulopathy.4 In the present study, semi-
quantitative evaluation of local disturbed flow pattern was
performed with videodensitometry with data obtained at
digital subtraction angiography (DSA). The relation be-
tween disturbed flow pattern in AAA and activation of the
coagulation-fibrinolytic system was studied.
MATERIALS AND METHODS
Patients. After they were referred to our hospital, 23
outpatients underwent spiral computed tomography (CT).
Axial reconstruction was obtained at 3 mm intervals, and
the image data sets were transferred to an AdvantageWork-
station 3.1 (GE YokokawaMedical Systems, Tokyo, Japan)
to construct three-dimensional CT angiography (3DCTA)
images. Patients were further evaluated with interviews,
electrocardiography, and ultrasonic cardiography. Distri-
bution of contrast agent is apparently influenced by cardiac
function and vascular occlusive disease. The coagulation
system is evidently affected by inherent coagulopathic dis-
orders. To minimize these effects, patients with coronary
disease, ejection fraction less than 0.50, ankle-brachial in-
dex less than 1.0, or with a history of coagulation abnor-
mality were excluded from the study. Because FDP-DD
may be increased as an acute phase reactant, patients with
C-reactive protein greater 0.1 also were excluded. In-
formed consent was obtained from each patient.
Coagulation parameters. Venous blood samples
were collected from the patients’ forearms to determine
C-reactive protein (CRP) concentration, platelet count,
prothrombin rate, activated partial thromboplastin time,
fibrinogen concentration, FDP-DD, and TAT. Quantita-
tive D-dimer and TAT levels were determined with an
enzyme-linked immunosorbent assay.
Morphologic analysis. Curved linear reconstructed
images in each patient, which provided accurate measure-
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ment of the diameters of the aorta and iliac arteries and
enabled selection of segments for length measurement,
were obtained with 3D CTA.5 With these images, calcula-
tions were made of maximum endoluminal diameter (di-
ameter of flow channel) between the superior mesenteric
artery and the highest opening of the left or right renal
artery (RSRAo), maximum AAA endoluminal diameter
(Rendomax), and maximum AAA diameter (eg,. wall-to-wall
diameter, RmaxAD). R ratio was defined as the ratio of
Rendomax to RSRAo.
In each axially reconstructed image, the lumen and the
thrombus are easily differentiated with intravascular injec-
tion of contrast material. Three-dimensional reconstruc-
tion of AAA endolumen and mural thrombus was per-
formed with a process based on CT findings. The
endoluminal surface of mural thrombus or total thrombus
volume also were calculated with image analysis software on
the Advantage Workstation 3.1 (GE Yokokawa Medical
Systems).
Angiography. With the patient under local anesthe-
sia, a 4F catheter (110 cm; Jet Balance; Terumo, Tokyo,
Japan) was inserted from the right femoral artery, and the
pigtail tip was placed in the abdominal aorta between the
openings of the superior mesenteric and renal arteries.
Fluoroscopic imaging was performed with Advantx LCN
Plus (GE Yokokawa Medical Systems). The image intensi-
fier was placed about 2 cm above the patient. Patients were
directed to hold their breath, and masked images were
recorded. After recording these images, 20 mL of 75.52%
iopamidol (Iopamiron 370; Nihon Schering, Osaka, Japan)
was injected at 10 mL/s. Fluoroscopic images were re-
corded at 0.09, 0.62, 1.15, 1.69, 2.22, 2.75, 3.29, 3.94,
4.88, 5.82, 6.74, 7.68, 8.86, and 10.86 seconds after the
injection. Thereafter, 3D rotation DSA or DSA at higher
volume and flow rate was performed if necessary.
Videodensitometric analysis. In each 3D CTA im-
age, one region of interest was located at the center (SRAo)
of the axial plane of the abdominal aorta, including the
openings of the renal arteries. A region of interest inside the
AAA lumen was located 8 cm peripheral from the SRAo
along the axial line. Regions of interest in the right and left
common iliac arteries were located 13 cm peripheral from
the SRAo. These distances were decided retrospectively so
that these regions of interest would be located inside the
designated arterial segments. Then the four rectangular
regions of interest (40 pixels) were located on the 2D DSA
image, with reference to the anteroposterior CTA image
(Fig 1). Images were recorded and analyzed at resolution of
29  29 pixels with a gray scale of 10-bit accuracy, where
white  0 and black  210.
Average gray scale values of pixels in the regions of
interest were measured at the aforementioned time points
to obtain time-density curves (Fig 2). Time points when
average gray scales of regions of interest reached maximum
(Tmax) were directly obtained from the curves. Time points
when average region of interest gray scales decreased to
half-maximum values (Thalf) were calculated after replot-
ting the downward portion of the curves into semilogarith-
mic form.6 Bolus transit time (BTT) was defined as dura-
tion between Tmax and Thalf,
7 and flow reduction rate as
ratio of BTTAAA to BTTSRAo. In each examination, Tmax at
the common iliac artery (TmaxCIA) was measured bilater-
Fig 1. Regions of interest were set on the suprarenal portion of the
abdominal aorta (SRAo), the central part of the infrarenal abdom-
inal aortic aneurysm (ABAo), and the right common iliac artery
(RCIA) and left common iliac artery (LCIA). RRR, Right renal
artery. SRAo  ABAo, 80 mm; SRAo  RCIA/LCIA, 130 mm.
Fig 2. Videodensitometric analysis. T0, Time zero; Tmax, time
when average gray scale of a region of interest (ROI) reaches
maximum; T half, time when average ROI gray scales decrease to
half-maximum; bolus transit time, duration between Tmax and T
half; Imax, maximum intensity; 1/2 Imax, half-maximum inten-
sity.
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ally. Thereafter, TmaxCIA with the greater value was chosen
to represent bolus arrival time at the common iliac artery in
each case.
Flow pattern analysis. At review of sequential 2D
DSA, blood flow was classified into two patterns, ie, severe
turbulence (S) and nonsevere turbulence (N). Flow pat-
terns with apparent turbulence defined here contained
either presence of vortex pattern inside the AAA or retro-
grade filling of injected bolus inside the AAA lumen.
Statistical analysis. Data are presented as mean 
SD. A single correlation coefficient (Pearson correlation
coefficient) of all aforementioned morphologic data for
BTTAAA or TmaxCIA was calculated to determine the effec-
tive morphologic predictor among these data. Morpho-
logic or videodensitometric variables and FDP-DD or TAT
were statistically analyzed to assess factors associated with
activation of intravascular coagulation or fibrinolysis. Each
variable was categorized into either a morphologic or vid-
eodensitometric group. In each group, factors were further
assessed with a single correlation coefficient (Pearson cor-
relation coefficient), and factors with the higher correlation
coefficient for each other were treated as one subgroup. A
single (Pearson) correlation coefficient for all morphologic
and videodensitometric data was calculated for either
FDP-DD or TAT, and data that showed higher coefficient
values (r  .4; P  .05) were selected. To prevent multi-
colinearity, nomore than two variables from each subgroup
were used for multiple regression analysis. The most deter-
minant factors associated with increased FDP-DD or TAT
were thus determined with stepwise regression analysis. To
investigate the relation between flow pattern and videoden-
sitometric factors or coagulation or fibrinolysis markers,
values in either group S or N were compared with those in
the other group with the unpaired t test. P  .05 was
regarded as statistically significant.
RESULTS
Twenty-three patients with AAA seen between July
2000 and June 2001 were included in the study. Patient
characteristics are presented in Table I.
Bolus transit time in abdominal and pelvic arterial
segments. There was no statistically significant correla-
tion between ejection fraction and BTTSRAo (r.043; P
 .845). The variance of data BTTSRAo was relatively small
in these patients, while data were distributed with wider
ranges of standard deviations in the more distal segments
(Fig 3). A statistically significant correlation (r22 .30; P
.042) was detected between the R ratio and BTT in AAA
(Fig 4). Bolus arrival time in the common iliac artery, or
TmaxCIA, was also closely related to the R ratio (Fig 5). The
other morphologic factors did not show statistically signif-
icant correlations between BTTAAA or TmaxCIA (Table II).
Factors associated with FDP-DD. Variables with
the single correlation coefficient (r value) for FDP-DD
included maximum endoluminal diameter, R ratio, and
BTT in AAA (Table III). 3D calculated mural thrombus
did not show a significant correlation with FDP-DD (Fig
6). As shown in the following equation, the most efficient
predictor for FDP-DD was BTTAAA (r
2  0.448; P 
.005).
FDP-DD  8.647  2.029  BTTAAA
Factors associated with TAT. Variables with the
higher single correlation coefficient for TAT included max-
imum endoluminal diameter, R ratio, and BTTAAA (Table
III). As shown in the following equation, the most efficient
predictors for TAT were BTTAAA and maximum endolu-
minal diameter of AAA (r2  .360; P  .0069).
TAT  14.007  0.296  Rendomax  2.102
 BTTAAA
Flow reduction rate and flow pattern. Eleven cases
were classified into group S and 12 into groupN. There was
a significant difference (P  .0071) between groups for
flow reduction rate (group S, 12.3  8.4; group N, 4.5 
1.9), R ratio (group S, 2.49 0.55; group N, 1.94 0.53;
P .048), BTTAAA (group S, 9.79 2.22 seconds; group
N, 7.51  2.42 seconds; P  .0327), FDP-DD (group S,
11.3  7.9 g/mL; group N, 3.8  2.6 g/mL; P 
.008), and TAT (group S, 20.1  15.3 g/mL; group N,
9.1  6.0 g/mL; P  .046).
Table I. Demographic data for 23 study patients
Characteristic Value
Age (y) 72.6  6.6
Gender (%)
Male 95.7
Female 4.3
Ejection fraction 62.3  3.3
Platelet count
(106/mL)
17.5  4.3 (15.3–35.2)
PTTR (%) 107  12 (87–131)
aPTTR (%) 80.7  25.6 (58–131)
Fibrinogen (g/mL) 359.0  92.4 (178–360)
FDP-DD (g/ml) 7.66  6.86 (0.1)
TAT (g/ml) 15.6  12.6 (3.0)
Suprarenal abdominal
aortic diameter (mm)
18.8  1.6
Aneurysm diameter (mm)
Lumen 39.7  14.5
Wall 60.2  15.2
R ratio 2.2  0.7
Mural thrombus
Volume (mL) 44.5  50.5
Surface (cm2) 57.3  37.0
BTT AAA (s) 8.42  2.57
BTT SRAo (s) 1.49  0.71
Tmax in CIA (s) 6.51  1.54
Flow pattern
Severe turbulence (%) 48
No severe turbulence (%) 52
PTTR, Prothrombin time ratio; aPTTR, activated PTTR; FDP-DD, fibrin
degradation product D-dimer; TAT, thrombin-antithrombin complex; BTT,
bolus transit time; AAA, abdominal aortic aneurysm; SRA, maximum
endoluminal diameter between superior mesenteric artery and highest open-
ing of left or right renal artery; Tmax, time when average gray scale of region
of interest decreased to maximum value; CIA, common iliac artery.
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DISCUSSION
Graham et al8 first reported the dissecting aortic aneu-
rysm and a hemorrhagic diathesis, evidenced as petichiae,
gingival bleeding, and prolonged bleeding time from veni-
puncture sites. Although the combination of disseminated
intravascular coagulation and AAA is rare,9 in patients with
a bleeding tendency with thrombocytopenia and hypofibri-
nogenemia, preoperative control of consumption coagu-
lopathy is recommended to avert perioperative massive
bleeding, with high morbidity and mortality.10,11 Prepro-
cedural coagulation and fibrinolytic disorders in these pa-
tients warrant careful perioperative assessment, not only for
surgical treatment of AAA but also for endovascular proce-
dures.12
In the present study, blood samples were obtained with
venipuncture a few days before angiography. Strictly speak-
ing, the present study thus showed only a relation between
abnormalities in morphologic or videodensitometric vari-
ables and existence of intravascular coagulation in patients
with AAA. Previous studies, however, have shown that
111In–labeled platelet specifically accumulated inside the
AAA13 and that 111In-labeledmonoclonal antibody against
human tissue plasminogen activator accumulated specifi-
cally in the AAA wall.14 Therefore the increase in FDP-DD
and TAT in this study likely indicates the presence of
mechanisms that activate intravascular coagulation and fi-
brinolysis inside the AAA.
At rheology the appearance of turbulence can be ex-
pected from the Wormersley or Reynolds number, which
depends in part on the vessel diameter.3 Color Doppler
ultrasound studies have also shown that aneurysms with
larger endoluminal diameter have a turbulent circuitous
pattern of blood flow.15 In the present study, patients with
apparent severe turbulence inside the AAA had a larger R
ratio and longer BTT in the AAA. Consequently, there
appeared to be a close link between reduction of blood flow
rate inside the aneurysm and presence of severely disturbed
flow patterns.
FDP-DD or TAT in the patient group with apparent
turbulence was significantly higher than in the other group.
The pathophysiologic mechanisms by which the disturbed
flow pattern activates the coagulation-fibrinolysis system in
these patients has not been elucidated. Formation of
thrombus inside the AAA may result from injury in the
endothelium as a result of atherosclerotic degenerative
changes or mechanical injury caused by the vortex16in the
aneurysm wall. Low shear stress and reversed flowmay shift
the profile of secreted factors from endothelial cells and
expressed molecules,4 inducing platelet adhesion to the
vessel wall, which is less likely to occur in the normal flow
field in the artery.17
The volume of intramural thrombus diagnosed with
3D CTA did not appear to be necessarily related to in-
creased FDP-DD or TAT. It is highly likely that activation
Fig 3. Bolus transit time in aortoiliac lesions. SRAo, Suprarenal
portion of abdominal aorta. AAA, infrarenal abdominal aortic
aneurysm, RCIA, right common iliac artery; LCIA, left common
iliac artery; solid boxes, mean value; bars, standard deviation.
Fig 4. Bolus transit time in abdominal aortic aneurysm (AAA) and
endoluminal diameter of AAA. x-axis, Ratio of maximal endolumi-
nal diameter of AAA (Rendomax) to maximal endoluminal diameter
of abdominal aorta (RSRAO) between superior mesenteric and renal
arteries. y-axis, Bolus transit time in AAA.
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of coagulation and fibrinolysis occurs at the surface of the
endoluminal wall exposed to the abnormal flow field and
that upregulated production of FDP-DD or TAT may be
downregulated or normalized after the thrombus fills the
aneurysm wall. It is intriguing that there was a previous
report that consumption coagulopathy associated with ar-
terial aneurysm is self-limiting and ceases when the throm-
bus stops growing after filling the aneurysm lumen.18,19
Videodensitometric analysis as described has several
limitations. The subtracted image was recorded at the rate
of 1 to 3 images per second. Faster time-based analysis must
be performed to determine more specific flow analysis.
Furthermore, although 2D DSA enabled detection of se-
vere turbulence inside the AAA, more detailed flow pattern
analysis would require 3DDSAwith higher time and spatial
resolution. Therefore we cannot conclude which features of
flow pattern abnormalities (eg, disturbed flow such as vor-
tex, reduction of flow speed, shear stress change) would
contribute most to intravascular coagulation. Further stud-
ies are required to clarify the relationship between flow
abnormalities inside AAA and the increased coagulation
and fibrinolytic activity.
In conclusion, videodensitometric analysis with 2D
DSA enables semiquantitative evaluation of the severity of
disturbed flow patterns, which correlates with FDP-DD
and TAT in patients with AAA. The mechanisms of intra-
vascular coagulation in these patients warrants further in-
vestigation to increase safety of surgical or endovascular
treatment of AAA.
Fig 5. Bolus arrival time at common iliac artery and endoluminal
diameter of abdominal aortic aneurysm (AAA). x-axis, Ratio of
maximal endoluminal diameter of AAA (Rendomax) to maximal
endoluminal diameter of abdominal aorta (RSRAO) between supe-
rior mesenteric and renal arteries. y-axis, Bolus arrival time at
common iliac artery.
Table II. Single correlation coefficient between
morphologic factors and BTTAAA and TmaxCIA
Morphological factor BTTAAA TmaxCIA
RSRAo 0.256 (0.229) 0.096 (0.660)
Rendomax 0.328 (0.119) 0.285 (0.180)
RmaxAD 0.103 (0.635) 0.192 (0.374)
Rratio 0.547 (0.042) 0.519 (0.009)
BTTAAA, Bolus transit time to abdominal aortic aneurysm; TmaxCIA, time
when average gray scale of region of interest reaches maximum; RSRAo,
maximum endoluminal diameter between superior mesenteric artery and
highest opening of left or right renal artery; Rendomax,maximum endolumi-
nal diameter of aneurysm; RmaxAD, maximum wall-to-wall diameter of
aneurysm.
Table III. Single correlation coefficient for FDP-DD and
TAT
Variable FDP-DD TAT
Maximum absolute AAA diameter (cm) 0.171 0.277
Maximum endoluminal AAA diameter (cm) 0.434* 0.541*
R ratio 0.407* 0.481*
Thrombus surface (cm2) 0.056 0.130
Thrombus volume (mL) 0.100 0.103
Bolus transit time in SRAo (s) 0.059 0.214
Bolus transit time in AAA (s) 0.530* 0.515*
Bolus arrival time in CIA (s) 0.389 0.221
FDP-DD, fibrin degradation product D-dimer; TAT, thrombin-antithrom-
bin complex; AAA, abdominal aortic aneurysm; SRAo, maximum endolu-
minal diameter between superior mesenteric artery and highest opening of
left or right renal artery; CIA, common iliac artery.
*P  .05.
Fig 6. Fibrin degradation product D dimer (FDP-DD) and mural
thrombus volume.
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